Mechanistic validation through apoptotic protein expression analysis (P53, BCL2, BAX) confirmed that PRNP depletion potentiates gemcitabine-induced apoptosis in pancreatic cancer cells. This evidence concerns the gene TP53 and familial pancreatic carcinoma.